How to Leverage Portals to Facilitate a Risk-Based Monitoring Strategy
This year’s ClinTech will focus on educating participants in how clinical trial investigator portals can improve operational processes.
25 February 2014
Heightened R&D economic and regulatory concerns continue to change the clinical research model.
To ensure your clinical technology strategy achieves its organizational objectives for 2014, ClinTech, CBI’s Clinical Business and Technology Congress, a premier forum on optimizing business systems to accelerate clinical R&D, will hold its annual conference from March 11-13, in Cambridge, MA, at the Hyatt Regency Hotel.
This year’s event will focus on educating participants in how clinical trial investigator portals can improve operational processes for study start-up through study close and RBM strategies. As a means for communication, investigators can leverage investigator portals to receive documents from the site and to publish documents which can be incorporated into their ISF. On Tuesday, March 11th from 3:45-5:15 PM Kevin McNulty, Director of Life Sciences at Intralinks, will discuss how these portals can serve as a bridge between the ISF and the TMF by examining the benefits and challenges of implementing such a solution. In his presentation, “Leverage Portals to Facilitate a Risk-Based Monitoring Strategy” you’ll learn how a clinical portal allows a monitor to have insight into what is in and what is not in the ISF and reduce source document verification as part of a risk-based monitoring strategy.
We hope to see you there!
Meagan Parrish is the Senior Manager of Social Media at Intralinks. She is responsible for social media strategy development and the communications for Intralinks' online communities. Meagan has been creating social media strategies for a variety of companies across verticals for the past several years. She holds Bachelor degrees in Marketing and Finance, with a minor in English Literature.